Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Trends Immunol. 2012 Jun 20;33(10):522–530. doi: 10.1016/j.it.2012.05.008

Table 1.

List of ISGs with reported antiviral effector activity against infection by WNV and other flaviviruses

ISG Activity Mechanism of
Action
Flavivirus Reference
PKR Mice, primary
cells
Translation
inhibition?
Induction of IFN
WNV [44, 47, 71]
RNAse L Mice, primary
cells
Viral RNA
degradation?
Generation of
PAMP
WNV [47, 74]
Oas1b Mice, primary
cells
Reduction in 2′-5′
oligoA production
WNV, other
flaviviruses
[75, 76]
Viperin (rsad2) Mice, primary
cells, ectopic
expression
Modulation of
lipid biosynthesis
or droplet
formation?
WNV,
Dengue
[71, 83]
IFIT1 Mice, primary
cells
Translation
inhibition?
WNV [3, 89]
IFIT2 Ectopic
expression
Translation
inhibition?
WNV [3]
IFITM2 Ectopic
expression,
primary cells
Inhibition of
entry?
WNV,
Dengue
[71, 90]
IFITM3 Ectopic
expression,
primary cells
Inhibition of
entry?
WNV,
Yellow
fever
[66, 71, 87, 90]
ISG20 Ectopic
expression
Exonuclease? WNV,
Yellow
fever
[71, 88]
MB21D1 Ectopic
expression
Unknown WNV [66]
HPSE Ectopic
expression
Unknown WNV,
Yellow
fever
[66]
NAMPT Ectopic
expression
Unknown WNV [66]
TRIM79α Ectopic
expression,
primary cells
Degrades viral
RNA polymerase
Tick-borne
encephalitis
[91]

Note, ISGs that inhibit flaviviruses other than WNV and their corresponding references are added for completeness but not necessarily discussed in the text.

HHS Vulnerability Disclosure